FDA Drugs (New Approvals & NDA)Original article
Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
RegulatoryNeutral
AI Analysis
Summary
The FDA issues non-compliance letters under Section 505B(d)(1) to sponsors who fail to submit required pediatric assessments by the deadline or do not seek deferrals under PREA regulations.
Outcome Details
FDA sends PREA Non-Compliance letters to sponsors who failed to submit pediatric assessments by final due date or failed to seek/obtain deferrals
Importance:2/10
Sentiment:
0.00
PREAPediatric AssessmentRegulatory ComplianceFDANon-Compliance
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 25, 2026 9:36 PM